CoraLite® Plus 647 Anti-Human CD300a Rabbit Recombinant Antibody

CD300a Uni-rAbTM Recombinant Antibody for FC
Cat No. CL647-98268
Clone No.242131H4

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

242131H4, CD300 antigen-like family member A, CD300a molecule, CLM 8, CLM-8

Formulation:  PBS and Azide
PBS and Azide
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive FC detected inhuman peripheral blood leukocytes

Recommended dilution

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

Product Information

CL647-98268 targets CD300a in FC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen Recombinant protein Predict reactive species
Full Name CD300a molecule
Calculated Molecular Weight33 kDa
GenBank Accession NumberNM_007261.4
Gene Symbol CD300a
Gene ID (NCBI) 11314
Conjugate CoraLite® Plus 647 Fluorescent Dye
Excitation/Emission Maxima Wavelengths654 nm / 674 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ9UGN4-1
Storage Buffer PBS with 0.09% sodium azide and 0.5% BSA
Storage ConditionsStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Background Information

Human CD300a is a transmembrane protein, with an immunoglobulin (Ig)V-like extracellular domain and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs), providing the receptor with an inhibitory capacity. The relevance of the CD300a molecule in several pathological conditions has been highlighted by multiple studies. (PMID: 37762055)

Protocols

Product Specific Protocols
FC protocol for CL Plus 647 CD300a antibody CL647-98268Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...